Physicians Office Resource Volume 8 Issue 08 | Page 23

PHYSICIANS OFFICE RESOURCE NEWS BRIEFS Selected by POR Editorial Board R educed Risk of Brain Injury on MRI With Early EPO in Preemies Early administration of high-dose erythropoietin is associated with a reduced risk of brain injury on magnetic resonance imaging (MRI) in premature infants, according to research published in the Aug. 27 issue of the Journal of the American Medical Association. Russia HaVinh Leuchter, M.D., of the University Hospital of Geneva, and colleagues randomly assigned infants to receive recombinant human erythropoietin (256 participants) or placebo (239 participants) intravenously before three hours, at 12 to 18 hours, and at 36 to 42 hours after birth. Magnetic resonance imaging (MRI) scans acquired at term-equivalent age were evaluated for a nonrandomized subset of 77 infants receiving erythropoietin and 88 infants receiving placebo. The researchers found that at term-equivalent age, fewer infants in the erythropoietin group, compared with the placebo group, had abnormal scores for white matter injury, white matter signal intensity, periventricular white matter loss, and gray matter injury. The birth weight-adjusted risk ratio for infants receiving erythropoietin versus placebo was 0.58 (95 percent confidence interval [CI], 0.35 to 0.96) for white matter injury; 0.20 (95 percent CI, 0.05 to 0.90) for white matter signal intensity; 0.53 (95 percent CI, 0.30 to 0.92) for periventricular white matter loss; and 0.34 (95 percent CI, 0.13 to 0.89) for gray matter injury. "In an analysis of secondary outcomes of a randomized clinical trial of preterm infants, high-dose erythropoietin treatment within 42 hours after birth was associated with a reduced risk of brain injury on MRI," the authors write. Two authors disclosed receiving research grants from Nestle. H ealth Care Protective Gear Lacking in Ebola Outbreak Health care workers in poor nations often do not have enough protective gear to keep them safe from being infected with bloodborne viruses such as Ebola and HIV, according to a study published online Aug. 8 in Tropical Medicine & International Health. The Hopkins researchers analyzed data from 399 hospitals in 13 low- and middleincome nations: Afghanistan, Bolivia, Gambia, Ghana, Liberia, Mongolia, Nigeria, Sierra Leone, Solomon Islands, Somalia, Sri Lanka, Tanzania, and Zambia. Overall, only 29 percent of the hospitals in the study always had eye protection for staff, 64 percent always had sterilizing equipment, and 75 percent always had sterile gloves. Rates varied widely among countries. For example, all hospitals in Bolivia and Nigeria had sterile gloves, compared with onequarter of hospitals in Afghanistan. None of the countries had 100 percent availability of all the protective items, which are standard in American hospitals. Prevention of HIV infection was the focus of this study, but the Ebola virus is spread in the same way, through 23 www.PhysiciansOfficeResource.com